Literature DB >> 16516234

Altered lymphocyte distribution in Alzheimer's disease.

Elke Richartz-Salzburger1, Anil Batra, Elke Stransky, Christoph Laske, Niklas Köhler, Mathias Bartels, Gerhard Buchkremer, Klaus Schott.   

Abstract

The contribution of immunological factors in the etiopathogenesis of Alzheimer's disease (AD) is increasingly noted. Apart from cerebral immunological findings, peripheral changes of the immune systems have been reported including lymphocyte function and subset distribution. As data still remain inconsistent, we investigated a sample of 43 patients with AD and of 34 healthy age-matched controls. Distribution of the T-, B- and NK cell subsets was determined by flow cytometry (FACS). We found a significant decrease of CD3(+) lymphocytes as well as of CD19(+) lymphocytes. A slight increase of the CD4(+) and a decrease of the CD8(+) subpopulation could be observed, without significant change of the CD4(+)/CD8(+) ratio. CD16(+)56(+) cells were not altered. Our findings of decreased T- and B-Cell numbers in AD sustain the hypothesis of a general decline of immune activity in AD. A putative association with premature immunosenescence in AD and possible pathogenetic implications are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16516234     DOI: 10.1016/j.jpsychires.2006.01.010

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  63 in total

Review 1.  Systemic inflammatory cells fight off neurodegenerative disease.

Authors:  Michal Schwartz; Ravid Shechter
Journal:  Nat Rev Neurol       Date:  2010-06-08       Impact factor: 42.937

2.  Perforin Promotes Amyloid Beta Internalisation in Neurons.

Authors:  Erica Lana; Mahbod Khanbolouki; Charline Degavre; Eva-Britt Samuelsson; Elisabet Åkesson; Bengt Winblad; Evren Alici; Christina Unger Lithner; Homira Behbahani
Journal:  Mol Neurobiol       Date:  2016-01-16       Impact factor: 5.590

Review 3.  The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's Disease.

Authors:  Gholamreza Azizi; Shadi S Navabi; Ahmed Al-Shukaili; Mir H Seyedzadeh; Reza Yazdani; Abbas Mirshafiey
Journal:  Sultan Qaboos Univ Med J       Date:  2015-08-24

4.  Aging enhances release of exosomal cytokine mRNAs by Aβ1-42-stimulated macrophages.

Authors:  Masato Mitsuhashi; Dennis D Taub; Dimitrios Kapogiannis; Erez Eitan; Linda Zukley; Mark P Mattson; Luigi Ferrucci; Janice B Schwartz; Edward J Goetzl
Journal:  FASEB J       Date:  2013-09-06       Impact factor: 5.191

5.  Immunophenotypes in the circulation of patients with mild cognitive impairment.

Authors:  Shino Magaki; Steven M Yellon; Claudius Mueller; Wolff M Kirsch
Journal:  J Psychiatr Res       Date:  2007-02-23       Impact factor: 4.791

6.  Systemic immune system alterations in early stages of Alzheimer's disease.

Authors:  Rongzhen Zhang; Robert G Miller; Catherine Madison; Xia Jin; Ronald Honrada; Will Harris; Jonathan Katz; Dallas A Forshew; Michael S McGrath
Journal:  J Neuroimmunol       Date:  2013-02-04       Impact factor: 3.478

Review 7.  CREB signals as PBMC-based biomarkers of cognitive dysfunction: A novel perspective of the brain-immune axis.

Authors:  Nancy Bartolotti; Orly Lazarov
Journal:  Brain Behav Immun       Date:  2019-01-12       Impact factor: 7.217

Review 8.  Can peripheral leukocytes be used as Alzheimer's disease biomarkers?

Authors:  Kavon Rezai-Zadeh; David Gate; Christine A Szekely; Terrence Town
Journal:  Expert Rev Neurother       Date:  2009-11       Impact factor: 4.618

Review 9.  Can infections cause Alzheimer's disease?

Authors:  Francis Mawanda; Robert Wallace
Journal:  Epidemiol Rev       Date:  2013-01-24       Impact factor: 6.222

Review 10.  Inflammaging as a prodrome to Alzheimer's disease.

Authors:  Brian Giunta; Francisco Fernandez; William V Nikolic; Demian Obregon; Elona Rrapo; Terrence Town; Jun Tan
Journal:  J Neuroinflammation       Date:  2008-11-11       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.